Researchers from the National Cancer Institute (NCI) have identified a two-drug combination that reduces growth Ewing sarcoma tumors in mice better than either drug alone. One of the drugs, vincristine, is a chemotherapy agent that is part of the standard treatment for patients with Ewing sarcoma. The other, YK-4-279, is an experimental drug that targets an abnormality, called a fusion protein, that…

Read more →